However, obesity-induced leptin and/or insulin resistance could thwart such tumor-suppressing activity by miR-4443 on TRAF4/NCOA1 and lead to potentiating the risks for CRC clinical presentation in obese individuals [58]. The gene discussed is LEP; the disease is colorectal carcinoma.